H-1152 markedly inhibited the growth in vivo of TEAD/YAP-driven MDA-MB-468 and MDA-MB-231 breast tumors harboring endogenous p53 DNA contact or both NF2 and p53 DNA contact mutations, respectively (Fig. 5a). The gene discussed is TP53; the disease is breast neoplasm.